Skip to content

Orphan Drugs: EMA’s COMP March 2013 Meeting Results

March 22, 2013

EMA’s Committee for Orphan Medicinal Products (COMP) held a meeting March 12 – 13 2013. The EMA COMP March 2013 Meeting Report on the review of applications for orphan designation is published March 21, 2013. At this meeting, there are 7 positive opinions recommending orphan designation for the treatment of :

  1. Follicular Thyroid Cancer
  2. Papillary  Thyroid Cancer
  3. Glioma
  4. Chronic Lymphocytic Leukemai/Small Lymphocytic Lymphoma
  5. Niemann-Pick Disease
  6. Idiopathic Pulmonary Fibrosis
  7. Duchenne Muscular Dystrophy.

    2013 EMA COMP Calendar

  1. April 16 – 17, 2013
  2. May 14 – 15, 2013
  3. June 11 – 12, 2013
  4. July 9 – 10, 2013
  5. September 3 – 4, 2013
  6. October 8 – 9, 2013
  7. November 5 – 6, 2013
  8. December 10 – 11, 2013.

Please Note: “Purple Check” by Rocket000 [Public domain] | Wikimedia Commons.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: